Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 23;8(7):1012-1026.
doi: 10.1002/mdc3.13319. eCollection 2021 Oct.

The Cholinergic Brain in Parkinson's Disease

Affiliations
Review

The Cholinergic Brain in Parkinson's Disease

Jacopo Pasquini et al. Mov Disord Clin Pract. .

Abstract

The central cholinergic system includes the basal forebrain nuclei, mainly projecting to the cortex, the mesopontine tegmental nuclei, mainly projecting to the thalamus and subcortical structures, and other groups of projecting neurons and interneurons. This system regulates many functions of human behavior such as cognition, locomotion, and sleep. In Parkinson's disease (PD), disruption of central cholinergic transmission has been associated with cognitive decline, gait problems, freezing of gait (FOG), falls, REM sleep behavior disorder (RBD), neuropsychiatric manifestations, and olfactory dysfunction. Neuropathological and neuroimaging evidence suggests that basal forebrain pathology occurs simultaneously with nigrostriatal denervation, whereas pathology in the pontine nuclei may occur before the onset of motor symptoms. These studies have also detailed the clinical implications of cholinergic dysfunction in PD. Degeneration of basal forebrain nuclei and consequential cortical cholinergic denervation are associated with and may predict the subsequent development of cognitive decline and neuropsychiatric symptoms. Gait problems, FOG, and falls are associated with a complex dysfunction of both pontine and basal forebrain nuclei. Olfactory impairment is associated with cholinergic denervation of the limbic archicortex, specifically hippocampus and amygdala. Available evidence suggests that cholinergic dysfunction, alongside failure of the dopaminergic and other neurotransmitters systems, contributes to the generation of a specific set of clinical manifestations. Therefore, a "cholinergic phenotype" can be identified in people presenting with cognitive decline, falls, and RBD. In this review, we will summarize the organization of the central cholinergic system and the clinical correlates of cholinergic dysfunction in PD.

Keywords: Parkinson's disease; basal forebrain; cholinergic; dementia; falls.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they did not receive specific funding for this work. The authors declare that there are no conflicts of interest relevant to this work.

Figures

FIG. 1
FIG. 1
Cholinergic systems of the brain. Two major pathways project widely to different brain areas: basal‐forebrain cholinergic neurons (red), and pedunculopontine–lateral dorsal tegmental neurons (blue). Other cholinergic neurons include striatal interneurons (orange), cranial‐nerve nuclei (green circles), vestibular nuclei (purple); and spinal cord preganglionic and motor neurons (yellow) (reused with permission from Perry et al17). Abbreviations: nb: nucleus basalis of Meynert: ms: medial septal nucleus.

Similar articles

Cited by

References

    1. Mesulam MM, Mufson EJ, Wainer BH, Levey AI. Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1‐Ch6). Neuroscience 1983;10(4):1185–1201. - PubMed
    1. Picciotto MR, Higley MJ, Mineur YS. Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior. Neuron 2012;76(1):116–129. - PMC - PubMed
    1. Lewy FH. Pathologischen Anatomie der Paralysis Agitans. Dtsch Z Nervenheilk 1913;50:50–55.
    1. Müller MLTM, Bohnen NI, Kotagal V, Scott PJH, Koeppe RA, Frey KA, Albin RL. Clinical markers for identifying cholinergic deficits in Parkinson's disease. Mov Disord 2015;30(2):269–273. - PMC - PubMed
    1. Benagiano V, Virgintino D, Flace P, Girolamo F, Errede M, Roncali L, Ambrosi G. Choline acetyltransferase‐containing neurons in the human parietal neocortex. Eur J Histochem 2003;47(3):253–256. - PubMed

LinkOut - more resources